Page last updated: 2024-11-08
15-hydroxytestosterone
Description
15-hydroxytestosterone: RN given refers to (15alpha,17beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
15alpha-hydroxytestosterone : An androstanoid that is testosterone substituted by a alpha-hydroxy group at position 15. A natural product found in Daphnia magna exposed to the biocide tributyltin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 247021 |
CHEBI ID | 34161 |
SCHEMBL ID | 1901199 |
MeSH ID | M0108478 |
Synonyms (18)
Synonym |
nsc-60794 |
2226-70-2 |
nsc60794 |
15alpha-hydroxytestosterone |
15alpha,17beta-dihydroxyandrost-4-en-3-one |
15-hydroxytestosterone |
(8r,9s,10r,13s,14s,15s,17s)-15,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
t193o3374b , |
androst-4-en-3-one, 15,17-dihydroxy-, (15alpha,17beta)- |
nsc 60794 |
unii-t193o3374b |
SCHEMBL1901199 |
15.alpha.,17.beta.-dihydroxyandrost-4-en-3-one |
androst-4-en-3-one, 15.alpha.,17.beta.-dihydroxy- |
CHEBI:34161 |
DTXSID40176798 |
15alpha-hydroxy testosterone |
Q27104281 |
Research Excerpts
Dosage Studied
Roles (2)
Role | Description |
androgen | A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors. |
Daphnia magna metabolite | A Daphnia metabolite produced by the species Daphnia magna. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (4)
Class | Description |
3-oxo-Delta(4) steroid | A 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position. |
17beta-hydroxy steroid | A 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration. |
15alpha-hydroxy steroid | A 15-hydroxy steroid in which the hydroxy group at position 15 has an alpha-configuration. |
androstanoid | Any steroid based on an androstane skeleton and its derivatives. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.31
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.31 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.62 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |